AngioDynamics, Inc. (ANGO) Stock Price

ANGOStock

$11.24−4.10%52W

Market Cap$472.69M

P/E—

PEG Ratio1.41

Div yield—

Beta0.25

ANGO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-2.55%

Price vs S&P 500 (4W)-25.78%

PEG Ratio1.41

VGM Score43.59

P/CF (Annual)153.02x

Book Value / Share (Quarterly)$3.86

P/TBV (Annual)4.35x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-1.87%

Cash Flow / Share (Quarterly)$0.03

Price vs S&P 500 (YTD)-24.39%

Gross Margin (TTM)55.65%

Net Profit Margin (TTM)-10.12%

EPS (TTM)$-0.79

10-Day Avg Trading Volume1.38M

EPS Excl Extra (TTM)$-0.79

Revenue Growth (5Y)1.93%

EPS (Annual)$-0.88

ROI (Annual)-20.80%

Gross Margin (Annual)54.62%

Net Profit Margin (5Y Avg)-21.52%

Cash / Share (Quarterly)$0.80

Revenue Growth QoQ (YoY)6.87%

ROA (Last FY)-13.75%

Revenue Growth TTM (YoY)8.20%

EBITD / Share (TTM)$-0.62

ROE (5Y Avg)-29.97%

Operating Margin (TTM)-11.24%

Cash Flow / Share (Annual)$0.01

P/B Ratio2.88x

P/B Ratio (Quarterly)4.07x

Net Income / Employee (Annual)$-54,400

EV / Revenue (TTM)1.37x

Net Interest Coverage (TTM)-120.40x

ROA (TTM)-12.67%

EV / EBITDA (TTM)52.40x

EPS Incl Extra (Annual)$-0.88

Current Ratio (Annual)2.19x

Quick Ratio (Quarterly)1.32x

3-Month Avg Trading Volume0.58M

52-Week Price Return-4.10%

EV / Free Cash Flow (Annual)874.84x

Revenue / Employee (TTM)$482,000

Tangible BV / Share (Quarterly)$2.41

P/S Ratio (Annual)1.48x

Asset Turnover (Annual)1.20x

52-Week High$16.29

Operating Margin (5Y Avg)-22.71%

EPS Excl Extra (Annual)$-0.88

CapEx CAGR (5Y)-13.04%

Tangible BV CAGR (5Y)-17.46%

26-Week Price Return7.35%

Quick Ratio (Annual)1.37x

13-Week Price Return-16.80%

Total Debt / Equity (Annual)0.03x

Current Ratio (Quarterly)2.40x

Enterprise Value$444.42M

Revenue / Share Growth (5Y)0.29%

Asset Turnover (TTM)1.25x

Book Value / Share Growth (5Y)-18.49%

Revenue / Employee (Annual)$474,300

Inventory Turnover (Annual)2.54x

Pretax Margin (Annual)-11.34%

Cash / Share (Annual)$1.29

3-Month Return Std Dev52.64%

Gross Margin (5Y Avg)52.65%

Net Income / Employee (TTM)$-48,800

ROE (Last FY)-21.51%

Net Interest Coverage (Annual)-84.53x

EPS Basic Excl Extra (Annual)$-0.88

P/FCF (TTM)22.22x

Receivables Turnover (TTM)7.43x

EV / Free Cash Flow (TTM)307.77x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.79

Receivables Turnover (Annual)7.02x

ROI (TTM)-18.61%

P/S Ratio (TTM)1.45x

Pretax Margin (5Y Avg)-22.31%

Revenue / Share (Annual)$7.71

Tangible BV / Share (Annual)$2.48

Free OCF CAGR (5Y)-51.48%

Price vs S&P 500 (52W)-19.63%

Year-to-Date Return-12.46%

5-Day Price Return-1.40%

EPS Normalized (Annual)$-0.88

ROA (5Y Avg)-19.71%

Net Profit Margin (Annual)-11.48%

Month-to-Date Return-26.92%

Cash Flow / Share (TTM)$0.92

EBITD / Share (Annual)$-0.70

Operating Margin (Annual)-12.47%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)128.69x

ROI (5Y Avg)-29.32%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.79

P/TBV (Quarterly)6.53x

P/B Ratio (Annual)2.64x

Inventory Turnover (TTM)2.46x

Pretax Margin (TTM)-10.07%

Book Value / Share (Annual)$4.10

Price vs S&P 500 (13W)-19.49%

Beta0.25x

P/FCF (Annual)930.50x

Revenue / Share (TTM)$7.74

ROE (TTM)-19.25%

52-Week Low$9.39

vGradeC

gGradeD

mGradeC

vgmGradeC

ANGO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q3 2026	Oct 8, 2026	-$0.11	-$0.04	+64.70%(+$0.07)
Q2 2026	Jul 14, 2026	-$0.09	-$0.07	+22.22%(+$0.02)
Q1 2026	Apr 2, 2026	-$0.11	$0.02	+118.18%(+$0.13)
Q4 2025	Jan 6, 2026	-$0.10	$0.00	+100.00%(+$0.10)
Q3 2025	Oct 2, 2025	-$0.12	-$0.10	+18.92%(+$0.02)

ANGO Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.10

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About AngioDynamics, Inc.

AngioDynamics Inc develops and manufactures specialized medical devices for treating peripheral vascular disease and supporting oncology and surgical procedures. The company generates the majority of its revenue from sales to U.S. healthcare providers.

ANGO Next Earnings Report

Report dateJan 6, 2027

QuarterQ4 2026

Report timeBMO

EPS estimate-$0.07

Revenue estimate$84.27M

Also reporting on Jan 6, 2027

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for January 2027

ANGO Insider Transactions

SellJul 30, 2026
NIGHAN WARREN G JR
Officer
Shares: 23,370Value: $344,006

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for July 2026

Companies in Related Industries

MLABMesa Laboratories IncIndustrial Instruments
CTKBCytek Biosciences, Inc. Common StockLab Analytical Instruments
AVRAnteris Technologies Global Corp. Common StockOrthopedic & Prosthetic Devices
PACBPacific Biosciences of California, Inc.Lab Analytical Instruments
MASS908 Devices Inc. Common StockLab Analytical Instruments
SENSSenseonics Holdings, Inc. Common StockIndustrial Instruments
FOSLFossil Group, Inc.Watches & Clocks
PREPrenetics Global Limited Class A Ordinary ShareLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$9.39

High$16.29